How did MYGN's Q4 2024 earnings surprise investors?
4/12/2025 03:35am
Aime
Myriad Genetics (MYGN) delivered an earnings surprise of $0 for Q4 2024, reflecting a period of relative stability and no significant positive or negative surprises for investors1.
Source:
1.
MYGN Earnings Surprise in Fiscal 2024 Q4
more
less
Explore
Screener
Best looking stocks that are MACD Golden Cross
Analysis
What is the trend of APOG's stock price?
Learn
Step 2: Macro context and catalyst, please provide the best sources, websites, and why, in French.